-       Report 
   - July 2025
    -  175 Pages 
    Global
   
   From       €4036EUR$4,490USD£3,539GBP 
                -       Report 
   - September 2025
    -  250 Pages 
    Global
   
   From       €4036EUR$4,490USD£3,539GBP 
                      Racecadotril is a medication used to treat acute diarrhea in adults and children. It is a prodrug of thiorphan, an enkephalinase inhibitor, and works by inhibiting the breakdown of endogenous enkephalins, which are natural peptides that reduce intestinal motility. Racecadotril is used to reduce the duration and severity of acute diarrhea, and is available in both oral and intravenous formulations. It is generally well tolerated, with few side effects.
Racecadotril is used in the treatment of    gastrointestinal disorders, including acute diarrhea, irritable bowel syndrome, and inflammatory bowel disease. It is also used to treat acute gastroenteritis in children. Racecadotril is available in many countries, including the United States, Canada, Europe, and Australia.
Some companies in the Racecadotril market include Sanofi, Merck, Pfizer, Novartis, and GlaxoSmithKline. Show Less   Read more